rs1553496443

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_001365536.1(SCN9A):​c.417C>A​(p.Asn139Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000000698 in 1,432,118 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.0e-7 ( 0 hom. )

Consequence

SCN9A
NM_001365536.1 missense

Scores

14
4
1

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 3.95

Publications

0 publications found
Variant links:
Genes affected
SCN9A (HGNC:10597): (sodium voltage-gated channel alpha subunit 9) This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.93

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN9ANM_001365536.1 linkc.417C>A p.Asn139Lys missense_variant Exon 4 of 27 ENST00000642356.2 NP_001352465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN9AENST00000642356.2 linkc.417C>A p.Asn139Lys missense_variant Exon 4 of 27 NM_001365536.1 ENSP00000495601.1 Q15858-1
SCN9AENST00000303354.11 linkc.417C>A p.Asn139Lys missense_variant Exon 4 of 27 5 ENSP00000304748.7 Q15858-1
SCN9AENST00000409672.5 linkc.417C>A p.Asn139Lys missense_variant Exon 4 of 27 5 ENSP00000386306.1 Q15858-3
SCN9AENST00000645907.1 linkc.417C>A p.Asn139Lys missense_variant Exon 4 of 27 ENSP00000495983.1 Q15858-4
SCN9AENST00000454569.6 linkc.417C>A p.Asn139Lys missense_variant Exon 4 of 15 1 ENSP00000413212.2 A0A0C4DG82
SCN9AENST00000452182.2 linkc.417C>A p.Asn139Lys missense_variant Exon 5 of 11 1 ENSP00000393141.2 H7C064

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.98e-7
AC:
1
AN:
1432118
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
709326
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33092
American (AMR)
AF:
0.00
AC:
0
AN:
40612
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25602
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38986
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82080
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51852
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5732
European-Non Finnish (NFE)
AF:
9.13e-7
AC:
1
AN:
1094846
Other (OTH)
AF:
0.00
AC:
0
AN:
59316
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 25, 2017
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Feb 19, 2020
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.N139K variant (also known as c.417C>A), located in coding exon 3 of the SCN9A gene, results from a C to A substitution at nucleotide position 417. The asparagine at codon 139 is replaced by lysine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this variant is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Generalized epilepsy with febrile seizures plus, type 7;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Uncertain:1
Jun 18, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SCN9A protein function. ClinVar contains an entry for this variant (Variation ID: 448294). This variant has not been reported in the literature in individuals affected with SCN9A-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 139 of the SCN9A protein (p.Asn139Lys). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.26
D
BayesDel_noAF
Pathogenic
0.14
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.96
.;D;.;.;D;.;.;.
Eigen
Pathogenic
0.73
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.97
D;.;D;D;D;D;D;D
M_CAP
Pathogenic
0.30
D
MetaRNN
Pathogenic
0.93
D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
4.0
H;H;H;.;H;H;.;.
PhyloP100
3.9
PrimateAI
Uncertain
0.74
T
PROVEAN
Pathogenic
-5.6
D;.;.;.;.;D;.;.
REVEL
Pathogenic
0.90
Sift
Pathogenic
0.0
D;.;.;.;.;D;.;.
Sift4G
Pathogenic
0.0010
D;D;.;.;.;D;.;.
Polyphen
0.89
.;P;.;.;P;.;.;.
Vest4
0.91
MVP
0.92
MPC
0.18
ClinPred
1.0
D
GERP RS
4.2
Varity_R
0.98
gMVP
0.87
Mutation Taster
=10/90
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1553496443; hg19: chr2-167163070; API